Huons Global said Wednesday that it plans to move its headquarters and R&D center to a new complex in Pangyo, Gyeonggi Province, by 2022.

The company plans to invest 93 billion won ($81.9 million) to construct a 15-story building inside the Gyeonggi Province Pangyo Creative Economy Valley Special Planning Area, also known as I-Square.

After the completion of the new facility and R&D center, the company plans to unite all its businesses into the new compound, including Huons _휴온스, Humedix _휴메딕스, Hubena _휴베나, Huons Medicare _{휴온스메디케어}, Huons Natural _{휴온스내츄럴}, Biotopia _{바이오토피아} and Panace _파나시. Through the integration, the company aims to become a global healthcare group.

“Through the establishment of the new Pangyo building and R&D center, we expect the welfare of employees to improve,” said Yoon Sung-tae _윤성태, CEO of Huons Global _{휴온스 글로벌}. “The company also hopes to create synergy within the group.”